Yahoo
NasdaqGS - Nasdaq Real Time Price USD

Pacific Biosciences of California, Inc. (PACB)

2.8300 +0.3800 (+15.51%)
At close: October 28 at 4:00:00 PM EDT
2.7900 -0.0400 (-1.41%)
Pre-Market: 9:10:53 AM EDT
Trade PACB on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
159,271
160,005
154,014
200,521
128,304
Cost of Revenue
101,325
114,225
116,732
147,741
79,269
Gross Profit
57,946
45,780
37,282
52,780
49,035
Operating Expense
221,383
603,341
327,945
363,145
353,854
Operating Income
-163,437
-557,561
-290,663
-310,365
-304,819
Net Non Operating Interest Income Expense
-7,329
-6,954
-13,412
-14,343
-14,690
Other Income Expense
40,206
18,457
-5,460
6,549
5,261
Pretax Income
-130,560
-546,058
-309,535
-318,159
-314,248
Tax Provision
827
318
316
-11,424
0
Net Income Common Stockholders
-131,387
-546,376
-309,851
-306,735
-314,248
Diluted NI Available to Com Stockholders
-131,387
-546,376
-309,851
-306,735
-314,248
Basic EPS
-0.42
-1.82
-1.13
-1.21
-1.40
Diluted EPS
-0.42
-1.82
-1.59
-1.21
-1.40
Basic Average Shares
304,824.5000
299,959
274,488
253,629
224,550
Diluted Average Shares
304,824.5000
299,959
288,366
253,629
224,550
Total Operating Income as Reported
-133,041
-553,861
-474,313
-334,467
-307,196
Total Expenses
322,708
717,566
444,677
510,886
433,123
Net Income from Continuing & Discontinued Operation
-131,387
-546,376
-309,851
-306,735
-314,248
Normalized Income
-149,624.6000
-549,129.9100
-288,102.9809
-281,540.8600
-311,873.3770
Interest Expense
7,329
6,954
13,412
14,343
14,690
Net Interest Income
-7,329
-6,954
-13,412
-14,343
-14,690
EBIT
-123,231
-539,104
-296,123
-303,816
-299,558
EBITDA
-105,590
-152,692
-242,772
-277,282
-282,240
Reconciled Cost of Revenue
87,016
92,354
81,387
127,364
61,951
Reconciled Depreciation
17,641
386,412
53,351
26,534
17,318
Net Income from Continuing Operation Net Minority Interest
-131,387
-546,376
-309,851
-306,735
-314,248
Total Unusual Items Excluding Goodwill
30,396
3,700
-29,243
-26,135
-2,377
Total Unusual Items
30,396
3,700
-29,243
-26,135
-2,377
Normalized EBITDA
-135,986
-156,392
-213,529
-251,147
-279,863
Tax Rate for Calcs
0.0004
0.0003
0.0003
0
0
Tax Effect of Unusual Items
12,158.4000
946.0900
-7,494.9809
-940.8600
-2.3770
12/31/2022 - 10/27/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: